A detailed history of Price T Rowe Associates Inc transactions in Accuray Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 97,146 shares of ARAY stock, worth $177,777. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97,146
Previous 91,146 6.58%
Holding current value
$177,777
Previous $166,000 5.42%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.41 - $2.49 $8,460 - $14,940
6,000 Added 6.58%
97,146 $175,000
Q2 2024

Aug 14, 2024

BUY
$1.49 - $2.43 $26,820 - $43,740
18,000 Added 24.61%
91,146 $166,000
Q1 2024

May 15, 2024

BUY
$2.37 - $2.94 $15,601 - $19,354
6,583 Added 9.89%
73,146 $181,000
Q4 2023

Feb 14, 2024

BUY
$2.44 - $3.08 $3,672 - $4,635
1,505 Added 2.31%
66,563 $189,000
Q3 2023

Nov 14, 2023

BUY
$2.63 - $4.26 $4,315 - $6,990
1,641 Added 2.59%
65,058 $177,000
Q2 2023

Aug 14, 2023

SELL
$2.7 - $3.97 $355,257 - $522,360
-131,577 Reduced 67.48%
63,417 $246,000
Q3 2022

Nov 14, 2022

BUY
$1.92 - $2.97 $124,800 - $193,050
65,000 Added 50.0%
194,994 $406,000
Q2 2022

Aug 15, 2022

SELL
$1.76 - $3.52 $14,016 - $28,033
-7,964 Reduced 5.77%
129,994 $255,000
Q1 2022

May 16, 2022

BUY
$3.16 - $4.81 $5,372 - $8,176
1,700 Added 1.25%
137,958 $457,000
Q4 2021

Feb 14, 2022

BUY
$3.72 - $5.88 $72,495 - $114,589
19,488 Added 16.69%
136,258 $650,000
Q3 2021

Nov 15, 2021

BUY
$3.5 - $4.56 $70,367 - $91,678
20,105 Added 20.8%
116,770 $461,000
Q2 2021

Aug 16, 2021

SELL
$4.24 - $5.51 $71,359 - $92,733
-16,830 Reduced 14.83%
96,665 $437,000
Q1 2021

May 17, 2021

SELL
$4.25 - $5.89 $60,180 - $83,402
-14,160 Reduced 11.09%
113,495 $562,000
Q4 2020

Feb 16, 2021

BUY
$2.53 - $4.71 $322,967 - $601,255
127,655 New
127,655 $532,000

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $171M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.